Aurora Cannabis Inc. (ACB) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $4.06 (-0.49%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 11, 2023 | EBITDA Q3 | Piper Sandler | $1.00 | -75.4% |
| May 28, 2021 | Heather Balsky | Bank of America Securities | $8.75 | +115.6% |
| May 14, 2021 | Tamy Chen | BMO Capital | $8.00 | +97.0% |
Top Analysts Covering ACB
ACB vs Sector & Market
| Metric | ACB | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.25 | 2.41 |
| Analyst Count | — | 8 | 19 |
| Target Upside | +45.8% | +153002.0% | +21.5% |
| P/E Ratio | -6.23 | 3.48 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $77M | $90M | $108M | 2 |
| 2027-03-31 | $75M | $87M | $105M | 1 |
| 2027-06-30 | $83M | $96M | $116M | 2 |
| 2027-09-30 | $86M | $100M | $121M | 2 |
| 2027-12-31 | $90M | $104M | $126M | 1 |
| 2028-03-31 | $91M | $106M | $128M | 1 |
| 2029-03-31 | $312M | $359M | $406M | 1 |
| 2030-03-31 | $336M | $386M | $437M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.05 | $0.07 | $0.08 | 1 |
| 2027-03-31 | $0.01 | $0.02 | $0.02 | 1 |
| 2027-06-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2027-09-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2027-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2029-03-31 | $0.07 | $0.08 | $0.10 | 1 |
| 2030-03-31 | $0.31 | $0.38 | $0.44 | 1 |
Frequently Asked Questions
What is the analyst consensus for ACB?
The consensus among 0 analysts covering Aurora Cannabis Inc. (ACB) is — with an average price target of $5.92.
What is the highest price target for ACB?
The highest price target for ACB is $8.75, set by Heather Balsky at Bank of America Securities on 2021-05-28.
What is the lowest price target for ACB?
The lowest price target for ACB is $1.00, set by EBITDA Q3 at Piper Sandler on 2023-01-11.
How many analysts cover ACB?
0 analysts have issued ratings for Aurora Cannabis Inc. in the past 12 months.
Is ACB a buy or sell right now?
Based on 0 analyst ratings, ACB has a consensus rating of — with a +45.8% upside to the consensus target of $5.92.
What are the earnings estimates for ACB?
Analysts estimate ACB will report EPS of $0.07 for the period ending 2026-12-31, with revenue estimated at $90M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.